Literature DB >> 7494358

The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus.

A D Northeast1, K S Soo, L G Bobrow, P J Gaffney, K G Burnand.   

Abstract

PURPOSE: The aim of this study was to measure the distribution of endogenous plasminogen activators during thrombolysis with an endothelial-conserving model of laminated thrombosis.
METHODS: Thrombi were raised in the inferior vena cava of rats with thrombin and flow reduction. The thrombi, adjacent vein wall, and distant veins (the superior vena cava) were removed at intervals from 1 hour to 21 days from formation and then cryohomogenized and assayed with specific bioimmunoassays for tissue-type (t-PA) and urokinase-type plasminogen activators (u-PA).
RESULTS: The measured t-PA activity of the vein wall around the thrombus was reduced compared with the control inferior vena cava at 4 days. Both the u-PA and t-PA content of the thrombus increased progressively during thrombolysis. The t-PA activity increased significantly in the distant vein walls in the animals with thrombi. Immunocytochemistry and in situ hybridization localized the t-PA to a mononuclear cell infiltrate and showed up-regulation of mRNA for rat t-PA in these monocytes.
CONCLUSIONS: The local plasminogen activator response was predominantly within the thrombus itself. Increased t-PA activity was additionally found in distant veins but was reduced in the vessel wall adjacent to the thrombus. This is the first report to show that u-PA activity is increased within organizing thrombus in vivo and that most of the t-PA activity is localized to a monocyte infiltrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494358     DOI: 10.1016/s0741-5214(95)70041-2

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.

Authors:  S A Siefert; C Chabasse; S Mukhopadhyay; M H Hoofnagle; D K Strickland; R Sarkar; T M Antalis
Journal:  J Thromb Haemost       Date:  2014-09-30       Impact factor: 5.824

2.  HIF-1α and VEGF expression correlates with thrombus remodeling in cases of intravascular papillary endothelial hyperplasia.

Authors:  Sunzoo Kim; Jae Hun Jun; Jeongshik Kim; Do Won Kim; Yong Hyun Jang; Weon Ju Lee; Ho Yun Chung; Seok-Jong Lee
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

3.  Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo.

Authors:  Christine Chabasse; Suzanne A Siefert; Mohammed Chaudry; Mark H Hoofnagle; Brajesh K Lal; Rajabrata Sarkar
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2014-05-10

4.  Thrombosis recanalization by paeoniflorin through the upregulation of urokinase‑type plasminogen activator via the MAPK signaling pathway.

Authors:  Songshan Ye; Bingyu Mao; Lei Yang; Weiyun Fu; Junran Hou
Journal:  Mol Med Rep       Date:  2016-04-15       Impact factor: 2.952

5.  Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project.

Authors:  Farhan Shahid; Nur A Rahmat; Gregory Y H Lip; Eduard Shantsila
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

Review 6.  Reactive Oxygen Species in Venous Thrombosis.

Authors:  Clemens Gutmann; Richard Siow; Adam M Gwozdz; Prakash Saha; Alberto Smith
Journal:  Int J Mol Sci       Date:  2020-03-11       Impact factor: 5.923

7.  Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.

Authors:  Julia Humphries; James A Gossage; Bijan Modarai; Kevin G Burnand; Thomas H Sisson; Colin Murdoch; Alberto Smith
Journal:  J Vasc Surg       Date:  2009-08-22       Impact factor: 4.268

Review 8.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.